Consistently, blockade of CXCR2 systemically in mice instead of tumor cells only could reduce engraftment rates of tumor cells homing to liver after IR injury, indicating that CXCL1/CXCR2 signaling is critical in PARP-1-induced susceptibility of the liver to recurrence. This evidence concerns the gene PARP1 and neoplasm.